Enhanced response to dabrafenib plus trametinib in a patient with BRAFV600E lung cancer harboring an RNF43 variant of unknown significance: a case report by Ettore D’Argento, Antonio Vitale, Antonio Vitale, Jacopo Russo, Jacopo Russo, Angelo Minucci, Alessandra Cancellieri, Alessio Stefani, Alessio Stefani, Federico Monaca, Federico Monaca, Guido Horn, Guido Horn, Denis Occhipinti, Denis Occhipinti, Paola Troisi, Paola Troisi, Alessandro Scala, Alessandro Scala, Sara Polidori, Sara Polidori, Francesco D’Argento, Mariantonietta Di Salvatore, Emilio Bria, Emilio Bria, Giampaolo Tortora, Giampaolo Tortora

Get full text

Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Ita... by Alessandro Inno, Antonello Veccia, Ettore D’Argento, Floriana Morgillo, Elio Gregory Pizzutilo, Fabiana Vitiello, Alberto Pavan, Fiorella Lombardo, Marco Russano, Vincenzo Sforza, Francesca Colamartini, Carlo Genova, Rita Chiari, Antonella Cristofano, Alessandro Delconte, Emanuela Vattemi, Alessandra Dessi, Daniele Galanti, Simona Busato, Giovanni Palazzolo, Clementina Savastano, Antonio Bianco, Francesco Verderame, Cristina Mazzi, Fabiana Marchetti, Stefania Kinspergher, Denis Occhipinti, Carminia Maria Della Corte, Daniele Piscazzi, Marina Gilli, Emilio Bria, Orazio Caffo, Stefania Gori

Get full text